Journal Club: Onasemnogene Abeparvovec-xioi: Gene Therapy for Spinal Muscular Atrophy

Pittsburgh, PA US
August 19, 2021

This course was designed to educate staff members on the outcomes from clinical trials and other treatment options for patients. 

Target Audience

Registered Nurses 

Learning Objectives

After completing this event, the learner will be able to:

  • Verbalize the incidence, disease progression, and treatment options for SMA-1.2.
  • Describe the safety and efficacy outcomes of the START study

Additional Information

Course summary
Available credit: 
  • 1.00 ANCC
    UPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
  • 1.00 Attendance
Course opens: 
08/19/2021
Course expires: 
09/02/2021
Event starts: 
08/19/2021 - 7:00am
Event ends: 
08/19/2021 - 8:00am
UPMC Children's Hospital of Pittsburgh
4401 Penn Ave
Pittsburgh, PA 15224
United States

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

The maximum number of hours awarded for this Continuing Nursing Education activity is 1 contact hours.

 

Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.  

Available Credit

  • 1.00 ANCC
    UPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
  • 1.00 Attendance
Please login or register to take this course.